Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 study. [electronic resource] by
- Riedl, M A
- Aygören-Pürsün, E
- Baker, J
- Farkas, H
- Anderson, J
- Bernstein, J A
- Bouillet, L
- Busse, P
- Manning, M
- Magerl, M
- Gompels, M
- Huissoon, A P
- Longhurst, H
- Lumry, W
- Ritchie, B
- Shapiro, R
- Soteres, D
- Banerji, A
- Cancian, M
- Johnston, D T
- Craig, T J
- Launay, D
- Li, H H
- Liebhaber, M
- Nickel, T
- Offenberger, J
- Rae, W
- Schrijvers, R
- Triggiani, M
- Wedner, H J
- Dobo, S
- Cornpropst, M
- Clemons, D
- Fang, L
- Collis, P
- Sheridan, W P
- Maurer, M
Producer: 20190807
In:
Allergy vol. 73
Availability: No items available.
|